Skip to content

News

2011 SGO News: GI Risk Clarified for Bevacizumab

2011 SGO News: GI Risk Clarified for Bevacizumab

Ovarian cancer patients had a twofold greater risk of gastrointestinal adverse effects when bevacizumab was added to chemotherapy, but the angiogenesis inhibitor did not exacerbate other known risks for GI events, data from a large prospective trial showed.

2011 SGO News: Genetic Test May Spot Increased Risk for In...

2011 SGO News: Genetic Test May Spot Increased Risk for Inherited Ovarian Cancer

Ovarian cancer patients had a twofold greater risk of gastrointestinal adverse effects when bevacizumab was added to chemotherapy, but the angiogenesis inhibitor did not exacerbate other known risks for GI events, data from a large prospective trial showed.

2011 SGO News: Mutation Link to Ovarian Cancer Disputed

2011 SGO News: Mutation Link to Ovarian Cancer Disputed

Developers of a genetic-susceptibility test for ovarian cancer might have jumped the gun, according to an OCRF-funded research consortium that found no association between a KRAS mutation and risk of the cancer.

2011 SGO News: ESAs Linked to Mortality Risk in Ovarian Ca...

2011 SGO News: ESAs Linked to Mortality Risk in Ovarian Cancer

Cancer recurrence and death occurred significantly more often in ovarian cancer patients treated with erythropoietin-stimulating agents (ESAs), data from a retrospective cohort review showed.

2011 SGO News: MicroRNA May Help Predict Ovarian Cancer Re...

2011 SGO News: MicroRNA May Help Predict Ovarian Cancer Response

Changes in expression of a microRNA showed potential for predicting response to the angiogenesis inhibitor bevacizumab (Avastin) in recurrent serous ovarian cancer, according to results of a small study reported here.

OCRF Research Finds microRNA Regulates Cancer Stem Cells

OCRF Research Finds microRNA Regulates Cancer Stem Cells

11/08/2010 OCRF Grantee Lin Zhang, MD  Research has provided strong support for the ovarian cancer stem cell hypothesis, which proposes that a rare subpopulation of tumor cells—cancer stem cells– have the … Continued

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.